Rocket Pharmaceuticals (RCKT) Treasury Shares (2014 - 2026)

Rocket Pharmaceuticals (RCKT) has 5 years of Treasury Shares data on file, last reported at $47000.0 in Q2 2023.

• For the quarter ending Q2 2023, Treasury Shares changed N/A year-over-year to $47000.0; the trailing twelve-month figure through Jun 2023 stood at $47000.0 (changed N/A YoY), and the FY2022 full-year result was $47000.0, changed N/A from the prior year.
• Treasury Shares steadied at $47000.0 in Q2 2023, from $47000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $7.7 million in Q1 2026 to a low of $457709.0 in Q1 2022.
• A 5-year average of $3.3 million and a median of $2.7 million in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares slumped 92.07% in 2019 and plunged 77.91% in 2020, its largest moves.
• Tracing RCKT's Treasury Shares over 4 years: stood at $53000.0 in 2019, then soared by 43.4% to $76000.0 in 2020, then tumbled by 38.16% to $47000.0 in 2022, then changed by 0.0% to $47000.0 in 2023.
• Business Quant data shows RCKT's Treasury Shares at $47000.0 in Q2 2023, $47000.0 in Q1 2023, and $47000.0 in Q4 2022.